Bogazzi Fausto, Cosci Chiara, Sardella Chiara, Costa Aurelio, Manetti Luca, Gasperi Maurizio, Rossi Giuseppe, Bartalena Luigi, Martino Enio
Dipartimento di Endocrinologia e Metabolismo, Università di Pisa, Ospedale Cisanello, Via Paradisa 2, 56124 Pisa, Italy.
J Clin Endocrinol Metab. 2006 Apr;91(4):1351-6. doi: 10.1210/jc.2005-2500. Epub 2006 Jan 31.
Acromegaly seems to be associated with an increased prevalence of colonic adenomas, although factors affecting their development and recurrence of the latter are not fully known.
Seventy-nine patients with active acromegaly were prospectively followed up for 5 yr. Two hundred eighty healthy subjects served as controls. Colonoscopy and assessment of acromegaly activity were performed at 1-yr intervals. Acromegaly was defined as controlled if serum IGF-I levels were within the normal age-adjusted range.
Colonic adenomas were found in 26 of 79 acromegalic patients (32.9%) and 60 of 280 controls (21.4%) at baseline (P = 0.035, adjusted for age and sex, odds ratio 1.82, 95% confidence interval, 1.02-3.25). Seven patients had hyperplastic polyps; the remaining 46 acromegalic patients had no detectable lesions at baseline and did not develop adenomas during the study period. Of the 26 patients with colonic adenomas at baseline, 16 (61.5%) had at least one recurrence of colonic adenomas (P < 0.0001 vs. patients without colonic lesions at baseline), and multiple recurrences were more frequent in patients with uncontrolled acromegaly (66.7% vs. 17.6% in patients with controlled acromegaly, P = 0.028).
The first colonoscopy helps to identify acromegalic patients at high risk of developing colonic adenomas. If colonic adenomas are not present initially, it is unlikely that they develop thereafter, independently of metabolic control of acromegaly. Conversely, new lesions are frequent (and often multiple) in patients who already have colonic adenomas at baseline, particularly if acromegalic disease is poorly controlled by treatment.
肢端肥大症似乎与结肠腺瘤患病率增加有关,尽管影响其发生及后者复发的因素尚不完全清楚。
对79例活动期肢端肥大症患者进行了为期5年的前瞻性随访。280名健康受试者作为对照。每隔1年进行一次结肠镜检查及肢端肥大症活动度评估。若血清IGF-I水平在年龄校正后的正常范围内,则定义为肢端肥大症得到控制。
基线时,79例肢端肥大症患者中有26例(32.9%)发现结肠腺瘤,280名对照中有60例(21.4%)发现结肠腺瘤(P = 0.035,经年龄和性别校正后,优势比为1.82,95%置信区间为1.02 - 3.25)。7例患者有增生性息肉;其余46例肢端肥大症患者在基线时未发现可检测到的病变,且在研究期间未发生腺瘤。在基线时患有结肠腺瘤的26例患者中,16例(61.5%)至少有一次结肠腺瘤复发(与基线时无结肠病变的患者相比,P < 0.0001),且在肢端肥大症未得到控制的患者中多次复发更为常见(未控制的肢端肥大症患者中为66.7%,得到控制的肢端肥大症患者中为17.6%,P = 0.028)。
首次结肠镜检查有助于识别有发生结肠腺瘤高风险的肢端肥大症患者。如果最初不存在结肠腺瘤,那么此后它们不太可能发生,与肢端肥大症的代谢控制无关。相反,在基线时已有结肠腺瘤的患者中,尤其是如果肢端肥大症疾病经治疗控制不佳时,新病变很常见(且常为多发)。